Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
microsatellite instability-high cancer
Pharma
Merck's Keytruda doubles time to colorectal cancer progression
The results are out, and they’re practice-changing: Keytruda can double the time to progression in patients with certain types of colorectal cancer.
Carly Helfand
May 28, 2020 5:00pm
Merck looks for lead on BMS with Keytruda colorectal cancer win
Apr 2, 2020 11:14am
Bristol-Myers Squibb's Opdivo nabs MSI-H colorectal cancer nod
Aug 1, 2017 9:26am
Merck's Keytruda wins first-ever FDA nod in MSI-H cancer
May 23, 2017 4:11pm
